Cargando…
Immunological signature of patients with thymic epithelial tumors and Good syndrome
BACKGROUND: Thymic epithelial tumors (TETs) are frequently accompanied by Good Syndrome (GS), a rare immunodeficiency, characterized by hypogammaglobulinemia and peripheral B cell lymphopenia. TETs can be also associated to other immunological disorders, both immunodeficiency and autoimmunity. METHO...
Autores principales: | Malfitano, Anna Maria, D’Esposito, Vittoria, De Placido, Pietro, Tortora, Marianna, Ottaviano, Margaret, Pietroluongo, Erica, Morra, Rocco, Mucci, Brigitta, Napolitano, Fabiana, Montella, Liliana, Giuliano, Mario, De Placido, Sabino, Terracciano, Daniela, Palmieri, Giovannella, Formisano, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434000/ https://www.ncbi.nlm.nih.gov/pubmed/36059463 http://dx.doi.org/10.3389/fimmu.2022.908453 |
Ejemplares similares
-
The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?
por: Montella, Liliana, et al.
Publicado: (2022) -
Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response
por: Cernera, Gustavo, et al.
Publicado: (2023) -
The European Reference Network: the keystone for the management of rare thoracic cancers
por: Morra, Rocco, et al.
Publicado: (2022) -
Impaired seroconversion after SARS-CoV-2 mRNA vaccine in patients with thymic epithelial tumors
por: Pietroluongo, Erica, et al.
Publicado: (2023) -
Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype
por: Caltavituro, Aldo, et al.
Publicado: (2023)